Competence

Mahkota Medical Centre: Promoting Women Empowerment

Retrieved on: 
화요일, 5월 21, 2024
Yee, Partnership, Health, Nursing, Oncology, Culture, Woman, Workplace, Empowerment, Service, Professional, Ethics, Ambassador, Accreditation, Women's rights, Interface (computing), Communication, Job satisfaction, Survivor, Town square, Female, Education, Workforce, Safety, Breast cancer, Human, Morale, Attention, Environment, Compassion, Patient, Hope, Interview, Male, Silver Award, Growth, Non-governmental organization, Thrive, Competence

ACN: Can you share with us Mahkota Medical Centre's journey in promoting women empowerment within the organization, and how it aligns with your core values and mission?

Key Points: 
  • ACN: Can you share with us Mahkota Medical Centre's journey in promoting women empowerment within the organization, and how it aligns with your core values and mission?
  • Ms Teo Chin Yee: Mahkota Medical Centre's journey in promoting women empowerment within the organization is deeply rooted in our core values of Competence, Compassion, and Collaboration.
  • At Mahkota Medical Centre, our commitment to promoting women empowerment aligns seamlessly with our mission to provide exceptional healthcare services.
  • In summary, the accreditation process undertaken by Mahkota Medical Centre reinforces our dedication to promoting women empowerment and advancing gender equality within our workplace.

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1

Retrieved on: 
화요일, 5월 28, 2024
Commission, Telephone, European Medicines Agency, Agency, Scope, DPR, Administrator, Interface, International Organization for Standardization, Chapter Two, Access, Disclosure, IRIS, Product lifecycle, Letter, GDPR, PUI, European Commission, ID, General Data Protection Regulation, Reproduction, ISO, Annex, European, Use, OMS, API, Chapter One, Chapter Five, IAM, Identification, NCA, Safety, Marketing, Public, Administration, EAF, Iris, PLM, ABC, Chapter Three, Document, UI, Information management, Chapter Six, Person, Data management, EMA, RMS, International Organization (journal), User, Competence, Medical device

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1

Key Points: 
    • Training .................................................................................................................................................... 13

      Product Management Service (PMS) - Implementation of International Organization for
      Standardization (ISO) standards for the Identification of Medicinal Products (IDMP) in
      Europe
      EMA/676105/2019

      Page 2/13

      Summary of changes
      Following the publication of version 2 in February 2021, the following sections were updated:
      ?

      PMS Registration requirements;

      ?

      Access to data;

      ?

      Training.

    • Scope of this document
      This document has been developed with the goal of facilitating the maintenance and accessibility to
      data on medicinal products for human use in the EU.
    • Scope of PMS
      The scope of PMS is to have harmonised data and definitions to uniquely identify a medicinal product
      based on regulated information (e.g.
    • Therefore, users shall read this chapter in
      conjunction with the 'On-boarding of users to Substance, Product, Organisation and Referentials
      (SPOR) data services' document.
    • In order to start this process the user has to confirm the registration of the relevant organisation in
      Organisation Management Service (OMS).
    • Product Management Service (PMS) - Implementation of International Organization for
      Standardization (ISO) standards for the Identification of Medicinal Products (IDMP) in
      Europe
      EMA/676105/2019

      Page 4/13

      User can check whether the relevant organisation is in OMS by searching using 'Request Access for
      Organizations' at EMA account management.

    • Product Management Service (PMS) - Implementation of International Organization for
      Standardization (ISO) standards for the Identification of Medicinal Products (IDMP) in
      Europe
      EMA/676105/2019

      Page 10/13

      Is the user Organisation
      in OMS?

    • For further information on how data are classified please refer to EU IG
      Chapter 5 and Annex A to Chapter 5.
    • Product Management Service (PMS) - Implementation of International Organization for
      Standardization (ISO) standards for the Identification of Medicinal Products (IDMP) in
      Europe
      EMA/676105/2019

      Page 12/13

      5.

    • Additional information on the location of the training materials
      will be made available in future updates of this chapter.
    • At the time of the PMS go live foreseen in Q2 2024, users will have read-only privileges in PMS.
    • The
      enabling of the write privileges will be released for specific set of PMS data elements at later stage in
      Q4 2024.
    • Product Management Service (PMS) - Implementation of International Organization for
      Standardization (ISO) standards for the Identification of Medicinal Products (IDMP) in
      Europe
      EMA/676105/2019

      Page 13/13

Exploration Results Meyas Sand Gold Project - Sudan

Retrieved on: 
월요일, 5월 27, 2024
Perseus, Gold, Front-end loading, COVID-19, Documentation, Hydrogeology, FEED, Mineral Resources Limited, GSS, FID, National instrument, Forward, Acquisition, Competence, Competent person, Perception, PRU, Television

Perth, Western Australia/ May 27, 2024/Perseus Mining Limited (ASX/TSX: PRU) is pleased to provide an update on exploration activities and studies completed to date at its Meyas Sands Gold Project (MSGP) in Sudan.

Key Points: 
  • Perth, Western Australia/ May 27, 2024/Perseus Mining Limited (ASX/TSX: PRU) is pleased to provide an update on exploration activities and studies completed to date at its Meyas Sands Gold Project (MSGP) in Sudan.
  • This initial drill program is aimed at testing high priority exploration targets in the vicinity of the GSS deposit to follow up the drilling results that have been received to date.
  • The information in this report and the attachments that relate to exploration drilling results at the Meyas Sand Gold Project is based on, and fairly represents, information and supporting documentation prepared by Mr Glen Edwards, a Competent Person who is a Chartered Professional Geologist.
  • Such factors include, among others, the actual market price of gold, the actual results of current exploration, the actual results of future exploration, changes in project parameters as plans continue to be evaluated, as well as those factors disclosed in the Company’s publicly filed documents.

THE SINGLETON FOUNDATION FOR FINANCIAL LITERACY AND ENTREPRENEURSHIP PARTNERS WITH GAMMA PHI BETA TO PROMOTE FINANCIAL WELLNESS

Retrieved on: 
화요일, 5월 14, 2024
Woman, Partnership, Learning, Taboo, Knowledge, Financial literacy, Life, Competence, Character, Entrepreneurship, Management

LOS ANGELES, May 14, 2024 /PRNewswire/ -- The Singleton Foundation for Financial Literacy & Entrepreneurship announces today a partnership with the international organization Gamma Phi Beta to develop financial skills and entrepreneurial mindsets for their members, essential skills they will need in life. Money can be complex. College is an important time to develop strong financial skills to be able to meet the challenges of navigating life after. 

Key Points: 
  • LOS ANGELES, May 14, 2024 /PRNewswire/ -- The Singleton Foundation for Financial Literacy & Entrepreneurship announces today a partnership with the international organization Gamma Phi Beta to develop financial skills and entrepreneurial mindsets for their members, essential skills they will need in life.
  • College is an important time to develop strong financial skills to be able to meet the challenges of navigating life after.
  • Their commitment to inspiring entrepreneurship and enhancing financial competence strongly aligns with Gamma Phi Beta's aim of empowering women to lead with confidence and character" said Megan Smiley Wick Gamma Phi Beta CEO.
  • "We're honored to work with Gamma Phi Beta as they take a leadership role in providing these resources to their members.

Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges

Retrieved on: 
화요일, 5월 14, 2024
Partnership, Patient, Drug, Organization, Health, Respiratory disease, Drug development, Premature, Research, Competence, Neonatology, Pharmaceutical industry

PARMA, Italy, May 14, 2024 /PRNewswire/ -- Chiesi Group, a research-oriented international biopharmaceutical group, proudly announces the signing of a memorandum of understanding with Karolinska Institutet, a medical university.

Key Points: 
  • PARMA, Italy, May 14, 2024 /PRNewswire/ -- Chiesi Group, a research-oriented international biopharmaceutical group, proudly announces the signing of a memorandum of understanding with Karolinska Institutet, a medical university.
  • The agreement solidifies a commitment between the two organizations to collaborate on joint efforts aimed at advancing therapeutic solutions for urgent health challenges.
  • The landmark collaboration between Chiesi and Karolinska Institutet (KI), will accelerate research and development initiatives for respiratory diseases, rare diseases, diseases of prematurity, and other specialty care indications.
  • Chiesi Group and KI will exchange ideas, expertise, and resources to accelerate the translation of scientific discoveries into tangible healthcare solutions.

ClearDATA Achieves AWS Managed Security Services Provider Partner Competency, Ensuring Customers a Trusted, Verified, Quality Managed and Secure Cloud Partner

Retrieved on: 
목요일, 5월 9, 2024
Security Service, Amazon Web Services, Competence, City, Software, MSSP, Gen, PHI, WAF, Security, Immersion, AWS, Health, Specialization, Medical device

AUSTIN, Texas, May 9, 2024 /PRNewswire-PRWeb/ -- ClearDATA®, healthcare's only comprehensive provider of cloud, compliance, and security services and software, today announced it has achieved Amazon Web Services (AWS) Level 1 Managed Security Service Provider (MSSP) Competency status, solidifying its position among a select group of global organizations meeting AWS quality standards for managed security services.

Key Points: 
  • "This achievement cements our position as the trusted leader in cloud security within the healthcare industry," said Rick Froehlich, CEO of ClearDATA.
  • Achieving the AWS Level 1 MSSP Competency differentiates ClearDATA as an MSSP and AWS Partner with essential 24/7 managed cloud security skillsets to earn the distinction.
  • This milestone highlights the company's commitment to ensuring the security, identification, and protection of sensitive healthcare data in the cloud.
  • For more information about ClearDATA's AWS Level 1 Managed Security Services Provider Partner status and its upcoming AWS Immersion Events please visit cleardata.com.

Cyber Defense Magazine Names Cloud Security Alliance’s Certificate of Competence in Zero Trust (CCZT) a 2024 Global InfoSec Award Winner for Cutting-Edge Cybersecurity Training

Retrieved on: 
월요일, 5월 6, 2024
Technology, Security, Other Technology, Professional Services, Software, Small Business, Internet, Hardware, Data Management, Other Professional Services, Cloud, Certification, RSA Conference, Research, Competence, Cloud computing, Environment, Zero trust security model, SDP, Cloud Security Alliance, CISA, NIST, CSA, ZTT, Organization

(RSA Conference)--The Cloud Security Alliance (CSA), the world’s leading organization dedicated to defining standards, certifications, and best practices to help ensure a secure cloud computing environment, is pleased to announce that Cyber Defense Magazine has named its Certificate of Competence in Zero Trust (CCZT) as a Global InfoSec Award winner with the title of Cutting-Edge Cybersecurity Training.

Key Points: 
  • (RSA Conference)--The Cloud Security Alliance (CSA), the world’s leading organization dedicated to defining standards, certifications, and best practices to help ensure a secure cloud computing environment, is pleased to announce that Cyber Defense Magazine has named its Certificate of Competence in Zero Trust (CCZT) as a Global InfoSec Award winner with the title of Cutting-Edge Cybersecurity Training.
  • Based on the key concepts outlined in CSA's Zero Trust Training (ZTT) , the CCZT provides an in-depth understanding of Zero Trust architecture, its components, and its functioning.
  • “With Zero Trust established as the future of information security, a Zero Trust-based approach is fast becoming a requirement for organizations and a required skill for a range of security professionals.
  • Now in its 12th year, the Cyber Defense Global InfoSec awards honor startups, early stage, later stage, or public companies in the information security space who offer a forward-looking cybersecurity product or service.

Pan American Energy Announces Final Drill Results from 2023/2024 Program at the Big Mack Lithium Project, including 1.71% Li2O over 19.65 m at the Eleven Zone Pegmatite

Retrieved on: 
금요일, 4월 26, 2024
UAV, ICP-MS, ICP-AES, News, Bias, Big Mack, Competence, QA/QC, ISO, Calibration, ISO 9001, ISO/IEC 17025, NI 43-101, ALS, Gravity anomaly

Holes BM24-049 and BM24-050 were infill holes targeting the Big Mack Deposit, and BM24-059 was an infill hole on targeting the Eleven zone pegmatite.

Key Points: 
  • Holes BM24-049 and BM24-050 were infill holes targeting the Big Mack Deposit, and BM24-059 was an infill hole on targeting the Eleven zone pegmatite.
  • Visual core logging indicates that the predominant host mineral for the Big Mack pegmatites is petalite.
  • A thorough chain-of-custody and QA/QC program is being carried out on the ongoing drill program.
  • Sample lengths are ranging from 0.3 m – 1.5 m, dependant on internal zoning of the dykes, mineralization, and lithology contacts.

Eldorado Gold Reports First Quarter 2024 Financial and Operational Results; Steady Start to 2024

Retrieved on: 
목요일, 4월 25, 2024
AISC, Kinetics, Olympias, Competence, Depreciation, Progress, Eldorado Gold, Ventilation, Assessment, Public expenditure, Engineering, Gold, Tax, Steel, GM, Pond, Burns, Workforce, Palladium

VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (“Eldorado”, "Eldorado Gold" or “the Company”) today reports the Company’s financial and operational results for the first quarter of 2024.

Key Points: 
  • VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (“Eldorado”, "Eldorado Gold" or “the Company”) today reports the Company’s financial and operational results for the first quarter of 2024.
  • Production and cost outlook: The Company is maintaining its 2024 annual production guidance of 505,000 to 555,000 ounces of gold.
  • The increase was driven by increased gold production and gold sales and higher average realized gold price.
  • In addition to the Operational Readiness team, as at March 31, 2024, there were over 600 personnel on site which is expected to ramp up to 1,300 during 2024.

Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer

Retrieved on: 
수요일, 4월 17, 2024
Medication, Cancer, Competence, Statistics, Regulation, CHMP, ASX, Autoimmune disease, Competent authority, AEMPS, NSCLC, IMM, Pharmaceutical industry

SYDNEY, AUSTRALIA, April 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received positive feedback from the Spanish Agency for Medicines and Health Products (AEMPS) Competent Authority regarding the Company’s upcoming TACTI-004 Phase III trial of eftilagimod alpha (“efti”) for first line treatment of metastatic non-small cell lung cancer (1L NSCLC).

Key Points: 
  • SYDNEY, AUSTRALIA, April 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received positive feedback from the Spanish Agency for Medicines and Health Products (AEMPS) Competent Authority regarding the Company’s upcoming TACTI-004 Phase III trial of eftilagimod alpha (“efti”) for first line treatment of metastatic non-small cell lung cancer (1L NSCLC).
  • Immutep SVP, Regulatory & Strategy, Christian Mueller commented: “We continue to be pleased with our discussions with regulatory bodies around the world regarding our upcoming pivotal TACTI-004 trial and are thankful for the positive feedback and constructive guidance received by AEMPS.
  • Among the other items discussed at the meeting were general aspects of the trial design, including selection of the control arm and statistics, and the specificities of the patient population.
  • Additional interactions with regulatory agencies as well as with other stakeholders and potential partners are ongoing in a productive manner.